Divergent trophoblast responses to bacterial products mediated by TLRs

Journal of Immunology

Volumn 173, Issue 7, 2004, Pages 4286-4296

  Abrahams, Vikki M ^a   Bole Aldo, Paulomi ^a   Kim, Yeon Mee ^b   Straszewski Chavez, Shawn L ^a   Chaiworapongsa, Tinnakorn ^b   Romero, Roberto ^c   Mor, Gil ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; FAS ASSOCIATED DEATH DOMAIN PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; X LINKED INHIBITOR OF APOPTOSIS;

ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL PRODUCT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; INNATE IMMUNITY; INTRAUTERINE INFECTION; NORMAL HUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; TROPHOBLAST;

EID: 4644340557     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.7.4286     Document Type: Article

References (80)

1. Munn, D. H., M. Zhou, J. T. Attwood, I. Bondarev, S. J. Conway, B. Marshall, C. Brown, and A. L. Mellor. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191.
2. Abrahams, V. M., S. L. Straszewski-Chavez, S. Guller, and G. Mor. 2004. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol. Hum. Reprod. 10:55.
3. Moffett, A., and Y. W. Loke. 2004. The immunological paradox of pregnancy: a reappraisal. Placenta 25:1.
4. Guleria, I., and J. W. Pollard. 2000. The trophoblast is a component of the innate immune system during pregnancy. Nat. Med. 6:589.
5. von Dadelszen, P., and L. A. Magee. 2002. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet. Gynecol. Scand. 81:642.
6. Goncalves, L. F., T. Chaiworapongsa, and R. Romero. 2002. Intrauterine infection and prematurity. Ment. Retard. Dev. Disabil. Res. Rev. 8:3.
7. Romero, R., T. Chaiworapongsa, and J. Espinoza. 2003. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J. Nutr. 133:16685.
8. Arechavaleta-Velasco, F., H. Koi, J. F. Strauss, 3rd, and S. Parry. 2002. Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation? J. Reprod. Immunol. 55:113.
9. Hsu, C. D., and F. R. Witter. 1995. Urogenital infection in preeclampsia. Int. J. Gynaecol Obstet. 49:271.
10. Lament, R. F. 2003. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. BJOG 110(Suppl. 20):71.
11. Goldenberg, R. L., J. C. Hauth, and W. W. Andrews. 2000. Intrauterine infection and preterm delivery. N. Engl. J. Med. 342:1500.
12. Medzhitov, R., and C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298.
13. Anderson, K. V., L. Bokla, and C. Nusslein-Volhard. 1985. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42:791.
14. Lemaitre, B., E. Nicolas, L. Michaut, J. M. Reichhart, and J. A. Hoffmann. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973.
15. Williams, M. J., A. Rodriguez, D. A. Kimbrell, and E. D. Eldon. 1997. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J. 16:6120.
16. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335.
17. Zhang, D., G. Zhang, M. S. Hayden, M. B. Greenblatt, C. Bussey, R. A. Flavell, and S. Ghosh. 2004. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522.
18. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588.
19. Holmlund, U., G. Gebers, A. R. Dahlfors, B. Sandstedt, K. Bremme, E. S. Ekstrom, and A. Scheynius. 2002. Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology 107:145.
20. Kumazaki, K., M. Nakayama, I. Yanagihara, N. Suehara, and Y. Wada. 2004. Immunohistochemical distribution of Toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis. Hum. Pathol. 35:47.
21. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1.
22. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406.
23. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419.
24. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.
25. Roberts, J. M., and C. W. Redman. 1993. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341:1447.
26. Smith, G. C., M. F. Smith, M. B. McNay, and J. E. Fleming. 1998. First-trimester growth and the risk of low birth weight. N. Engl. J. Med. 339:1817.
27. Aschkenazi, S., S. Straszewski, K. M. Verwer, H. Foellmer, T. Rutherford, and G. Mor. 2002. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol. Reprod. 66:1853.
28. Chou, J. Y. 1978. Human placental cells transformed by tsA mutants of simian virus 40: a model system for the study of placental functions. Proc. Natl. Acad. Sci. USA 75:1409.
29. Graham, C. H., T. S. Hawley, R. G. Hawley, J. R. MacDougall, R. S. Kerbel, N. Khoo, and P. K. Lala. 1993. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp. Cell Res. 206:204.
30. Chinnaiyan, A. M., C. G. Tepper, M. F. Seidin, K. O'Rourke, F. C. Kischkel, S. Hellbardt, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:4961.
31. Mempel, M., V. Voelcker, G. Kollisch, C. Plank, R. Rad, M. Gerhard, C. Schnopp, P. Fraunberger, A. K. Walli, J. Ring, et al. 2003. Toll-like receptor expression in human keratinocytes: nuclear factor κB controlled gene activation by Staphylococcus aureus is Toll-like receptor 2 but not Toll-like receptor 4 or platelet activating factor receptor dependent. J. Invest. Dermatol. 121:1389.
32. Bulut, Y., E. Faure, L. Thomas, O. Equils, and M. Arditi. 2001. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167:987.
33. Abrahams, V. M., S. L. Straszewski, M. Kamsteeg, B. Hanczaruk, P. E. Schwartz, T. J. Rutherford, and G. Mor. 2003. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res. 63:5573.
34. Takeuchi, O., T. Kawai, P. F. Muhlradt, M. Morr, J. D. Radolf, A. Zychlinsky, K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933.
35. Takeuchi, O., S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, R. L. Modlin, and S. Akira. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:10.
36. Ozinsky, A., D. M. Underbill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97:13766.
37. Han, S. H., J. H. Kim, M. Martin, S. M. Michalek, and M. H. Nahm. 2003. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect. Immun. 71:5541.
38. Straszewski-Chavez, S. L., V. M. Abrahams, E. F. Funai, and G. Mor. 2004. X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol. Hum. Reprod. 10:33.
39. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3:745.
40. Aliprantis; A. O., R. B. Yang, D. S. Weiss, P. Godowski, and A. Zychlinsky. 2000. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19:3325.
41. Into, T., K. Kiura, M. Yasuda, H. Kataoka, N. Inoue, A. Hasebe, K. Takeda, S. Akira, and K. Shibata. 2004. Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-κB activation. Cell. Microbiol. 6:187.
42. Smith, S. C., P. N. Baker, and E. M. Symonds. 1997. Increased placental apoptosis in intrauterine growth restriction. Am. J. Obstet. Gynecol. 177:1395.
43. Allaire, A. D., K. A. Ballenger, S. R. Wells, M. J. McMahon, and B. A. Lessey. 2000. Placental apoptosis in preeclampsia. Obstet. Gynecol. 96:271.
44. Kakinuma, C., C. Kuwayama, N. Kaga, Y. Futamura, Y. Katsuki, and Y. Shibutani. 1997. Trophoblastic apoptosis in mice with preterm delivery and its suppression by urinary trypsin inhibitor. Obstet. Gynecol. 90:117.
45. Chuang, T. H., and R. J. Ulevitch. 2000. Cloning and characterization of a sub-family of human Toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Network 11:372.
46. Zarember, K. A., and P. J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168:554.
47. Gewirtz, A. T., T. A. Navas, S. Lyons, P. J. Godowski, and J. L. Madara. 2001. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167:1882.
48. Flo, T. H., O. Halaas, S. Torp, L. Ryan, E. Lien, B. Dybdahl, A. Sundan, and T. Espevik. 2001. Differential expression of Toll-like receptor 2 in human cells. J. Leukocyte Biol. 69:474.
49. Pivarcsi, A., L. Bodai, B. Rethi, A. Kenderessy-Szabo, A. Koreck, M. Szell, Z. Beer, Z. Bata-Csorgoo, M. Magocsi, E. Rajnavolgyi, et al. 2003. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int. Immunol. 15:721.
50. Yang, Q., P. Zhu, Z. Wang, and J. Jiang. 2002. Lipopolysaccharide upregulates the expression of Toll-like receptor 4 in human vascular endothelial cells. Chin. Med. J. 115:286.
51. Uronen-Hansson, H., J. Allen, M. Osman, G. Squires, N. Klein, and R. E. Callard. 2004. Toll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in response to internalized bacteria. Immunology 111:173.
52. Hornef, M. W., B. H. Normark, A. Vandewalle, and S. Normark. 2003. Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells. J. Exp. Med. 198:1225.
53. Burns, K., F. Martinon, C. Esslinger, H. Pahl, P. Schneider, J. L. Bodmer, F. Di Marco, L. French, and J. Tschopp. 1998. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273:12203.
54. Wesche, H., W. J. Henzel, W. Shillinglaw, S. Li, and Z. Cao. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837.
55. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443.
56. Akira, S. 2003. Toll-like receptor signaling. J. Biol. Chem. 278:38105.
57. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394.
58. Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736.
59. Lopez, M., L. M. Sly, Y. Luu, D. Young, H. Cooper, and N. E. Reiner. 2003. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J. Immunol. 170:2409.
60. Hajjar, A. M., D. S. O'Mahony, A. Ozinsky, D. M. Underhill, A. Aderem, S. J. Klebanoff, and C. B. Wilson. 2001. Cutting edge: functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenolsoluble modulin. J. Immunol. 166:15.
61. Barnhart, B. C., E. C. Alappat, and M. E. Peter. 2003. The CD95 type I/type II model. Semin. Immunol. 15:185.
62. Mor, G., S. Straszewski, and M. Kamsteeg. 2002. The Fas/FasL system in reproduction: survival and apoptosis. Scientific World Journal. 2:1828.
63. Takahashi, R., Q. Deveraux, I. Tamm, K. Welsh, N. Assa-Munt, G. S. Salvesen, and J. C. Reed. 1998. A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem. 173:7787.
64. Sun, C., M. Cai, R. P. Meadows, N. Xu, A. H. Gunasekera, J. Hermann, J. C. Wu, and S. W. Fesik. 2000. NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP. J. Biol. Chem. 275:33777.
65. Chen, G., and D. V. Goeddel. 2002. TNF-R1 signaling: a beautiful pathway. Science 296:1634.
66. Muzio, M., B. R. Stockwell, H. R. Stennicke, G. S. Salvesen, and V. M. Dixit. 1998. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:2926.
67. Nagata, S. 1999. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33:29.
68. Hardiman, G., F. L. Rock, S. Balasubramanian, R. A. Kastelein, and J. F. Bazan. 1996. Molecular characterization and modular analysis of human MyD88. Oncogene 13:2467.
69. Bannerman, D. D., J. C. Tupper, J. D. Kelly, R. K. Winn, and J. M. Harlan. 2002. The Fas-associated death domain protein suppresses activation of NF-κB by LPS and IL-1β. J. Clin. Invest. 109:419.
70. Shikama, Y., M. Yamada, and T. Miyashita. 2003. Caspase-8 and caspase-10 activate NF-κB through WP, NIK and IKKα kinases. Eur. J. Immunol. 33:1998.
71. Stephanou, A., T. M. Scarabelli, R. A. Knight, and D. S. Latchman. 2002. Antiapoptotic activity of the free caspase recruitment domain of procaspase-9: a novel endogenous rescue pathway in cell death. J. Biol. Chem, 277:13693.
72. Wang, C. Y., M. W. Mayo, R. G. Komeluk, D. V. Goeddel, and A. S. Baldwin, Jr. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281:1680.
73. Hsu, L. C., J. M. Park, K. Zhang, J. L. Luo, S. Maeda, R. J. Kaufman, L. Eckmann, D. G. Guiney, and M. Karin. 2004. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428:341.
74. Akira, S., and K. Hoshino. 2003. Myeloid differentiation factor 88-dependent and -independent pathways in Toll-like receptor signaling. J. Infect. Dis. 187(Suppl. 2):S356.
75. Sato, S., M. Sugiyama, M. Yamamoto, Y. Watanabe, T. Kawai, K. Takeda, and S. Akira. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIP) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-βB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171:4304.
76. Kaga, N., Y. Katsuki, M. Obata, and Y. Shibutani. 1996. Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am. J. Obstet. Gynecol. 174:754.
77. Baines, M. G., A. J. Duclos, A. R. de Fougerolles, and R. L. Gendron. 1996. Immunological prevention of spontaneous early embryo resorption is mediated by non-specific immunosimulation. Am. J. Reprod. Immunol. 35:34.
78. Ogando, D. G., D. Paz, M. Cella, and A. M. Franchi. 2003. The fundamental role of increased production of nitric oxide in lipopolysaccharide-induced embryonic resorption in mice. Reproduction 125:95.
79. Yui, J., M. Garcia-Lloret, T. G. Wegmann, and L. J. Guilbert. 1994. Cytotoxicity of tumour necrosis factor-α and γ-interferon against primary human placental trophoblasts. Placenta 15:819.
80. Crocker, I. P., S. Barratt, M. Kaur, and P. N. Baker. 2001. The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syncytiotrophoblasts. Placenta 22:822.